Clinical Trial Search

Primary: Diarrhea (as Reported by the Patient) — 9; 26 participants — p=0.002

Primary: Severity of Pruritis — 10.88; 9.76; 6.64; 5.12 units on a scale

Primary: Methacholine Challenge Test Result for Phase 2 — 1.19; 2.04 mg/ml — p=0.65

Primary: Change From Baseline to Week 24 in the Disease Activity Score 28 (DAS28) — -3.3; -1.8 Units on a scale

Primary: Percentage of Participants Who Achieved a Hepatitis B Virus (HBV) DNA Level <50 IU/mL at Week 12 by Polymerase Chain Reaction Testing — 5.6; 0.0 Percentage of participants

Primary: Core Study: Change From Baseline in the Alzheimer's Disease Cooperative Study-Activities of Daily Living-Severe Impairment Version (ADCS-ADL-SIV) Score at Week 24…

Primary: Renal Function in Patients Converted From Cyclosporine to Prograf — 0.05; 0; 0.10 Change in serum creatinine (mg/dL)

Primary: Whole Mouth Lobene Modified Gingival Index Between the Brushing Only Group and the Brushing + Flossing Group [30 Days] Units on the MGI Scale — 1.84; 1.73 units on a…

Primary: Feasibility of Randomizing a Cohort of Participants Meeting the Inclusion and Exclusion Criteria of the Study — 21 participants

Primary: Number of Participants With Sedation Success — 18; 24; 18; 21 Participants

Primary: Participant BMI — 36.0; 36.4; 36.3; 36.8 kg/m^2 — p==0.51

Primary: Hemoglobin Measurement g/dl — 66.2; 102.4 hemoglobin g/dl

Primary: Number of Participants With the Usage of Doripenem as Per the Approved Indication — 23; 0; 0; 0 Participants

Primary: Change From Baseline to Week 24 in Abdominal VAT Mass — -0.630; -0.403 kg — p=0.0244

Primary: The Percentage of Intent to Treat Participants Randomized and Treated in Each Arm Who Had Lab-measured A1c <6.5% at 24 Weeks of Treatment — 47; 12 percentage of…